Simultaneous automated and continuous monitoring of glucose and lactate in cell cultures
C-CIT Sensors launches its innovative and easy-to-handle single-use wireless bi-parametric metabolic monitoring system.
C-CIT Sensors has released its new sensor product allowing users to monitor glucose and lactate in-situ and over weeks using one single-use sensor.
The measurement of critical process parameters (CPP) such as glucose and lactate is key to the understanding, development and control of bioprocesses of different kinds. Most labs today rely on frequent sampling and off-line analytics in order to follow the dynamics of a cell culture’s growth and metabolic status. These procedures are often manually conducted resulting in error-prone and risky data acquisition and processing. Many of them consume valuable and significant amounts of cell culture volume (and product) over the complete process time and require high upfront investment for instrumentation.
CITSens MeMo is an electrochemical, enzyme-based sensor with the capacity to be used in defined cell culture media and blood.
The continuous online/in-situ measurement of glucose and lactate as offered by CITSens MeMo adds value to cell line, media and process development projects within the cell bioresearch and biopharma community. The sensor system is unique and delivers real-time information on a culture’s growth behaviour and metabolic state at any given time. Data is being generated at a 20-second frequency and continuously sent to a database via wireless communication out of a closed incubator. Using a smartphone, a round-the-clock observation of your cell culture is here. Through straightforward OPC server connectivity, process control based on the online measured kinetics of glucose consumption and/or lactate generation has become reality.
The benefits are evident: Easy and fast learning about a cell culture’s metabolic behaviour under a given condition and straightforward process development at lowest investment and running cost, no risk of contamination, in-time information and automation, better science and engineering.
The single-use sensor comes as a standard product (a reactor probe containing a PG13.5 thread or as a flow cell sensor) or can be custom-manufactured as a cap sensor fitting any of the widely used brands of different cell culture vessels (T-flask, shake flask, roller bottle).
The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance